• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部区域治疗肝癌:过去十年有何变化?

Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?

机构信息

Department of Internal Medicine, University of Chicago Medicine, 5841 South Maryland Avenue, Chicago, IL 60687, USA.

Department of Internal Medicine, Northwestern Memorial Hospital, 676 North St. Clair 19(th) Floor, Chicago, IL 60611, USA.

出版信息

Clin Liver Dis. 2020 Nov;24(4):681-700. doi: 10.1016/j.cld.2020.07.011.

DOI:10.1016/j.cld.2020.07.011
PMID:33012453
Abstract

The evolution of locoregional therapies in the last decade has been refined with improved patient selection and a development of a more personalized approach. In doing so, there has been associated improved outcomes and less toxicity. With the rapidly changing landscape of systemic therapy, the role of locoregional therapies alone or in combination for downstaging and curative intent will continue to evolve.

摘要

在过去十年中,随着患者选择的改善和更个性化方法的发展,局部区域治疗得到了改进。这样做的同时,也提高了治疗效果并降低了毒性。随着全身治疗领域的快速变化,局部区域治疗单独或联合应用于降期和治愈目的的作用将继续发展。

相似文献

1
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?局部区域治疗肝癌:过去十年有何变化?
Clin Liver Dis. 2020 Nov;24(4):681-700. doi: 10.1016/j.cld.2020.07.011.
2
Goals and targets for personalized therapy for HCC.肝癌个体化治疗的目标和靶点。
Hepatol Int. 2019 Mar;13(2):125-137. doi: 10.1007/s12072-018-9919-1. Epub 2019 Jan 1.
3
The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?肝移植降期治疗后的时机选择:等待还是不等待?
J Gastrointest Cancer. 2020 Dec;51(4):1152-1156. doi: 10.1007/s12029-020-00491-z.
4
Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.局部区域治疗在等待肝移植的肝细胞癌患者中的作用。
Am J Gastroenterol. 2021 Jan 1;116(1):57-67. doi: 10.14309/ajg.0000000000000999.
5
Hepatocellular carcinoma: locoregional and targeted therapies.肝细胞癌:局部区域和靶向治疗。
Gastroenterol Clin North Am. 2011 Sep;40(3):599-610. doi: 10.1016/j.gtc.2011.06.003.
6
What Should Be the Rules for Downstaging for Hepatocellular Carcinoma?肝癌降期治疗的规则应该是什么?
J Gastrointest Cancer. 2020 Dec;51(4):1148-1151. doi: 10.1007/s12029-020-00490-0.
7
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.肝细胞癌经动脉化疗栓塞与经动脉放射性栓塞治疗:治疗方式选择的优化
Hepatol Int. 2016 Nov;10(6):883-892. doi: 10.1007/s12072-016-9722-9. Epub 2016 Apr 28.
8
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.局部区域治疗在肝癌的分子和免疫治疗时代。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):293-313. doi: 10.1038/s41575-020-00395-0. Epub 2021 Jan 28.
9
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy.回顾性分析肝细胞癌经动脉区域性局部治疗的免疫效应:选择性内放射治疗(SIRT)联合免疫治疗的原理。
BMC Cancer. 2020 Feb 19;20(1):135. doi: 10.1186/s12885-020-6613-1.
10
Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.经动脉化疗栓塞术治疗后无法手术的肝细胞癌行热消融与立体定向体部放疗的疗效比较:倾向评分加权分析。
AJR Am J Roentgenol. 2021 Sep;217(3):691-698. doi: 10.2214/AJR.20.24117. Epub 2020 Sep 30.

引用本文的文献

1
Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma.不可切除肝细胞癌的多学科护理与多模式治疗方法
Adv Oncol. 2024 May;4(1):247-262. doi: 10.1016/j.yao.2024.02.002. Epub 2024 Feb 23.
2
Predictive Biomarkers of Immune Checkpoint Inhibitor-Based Mono- and Combination Therapies for Hepatocellular Carcinoma.基于免疫检查点抑制剂的肝细胞癌单药及联合治疗的预测生物标志物
J Cancer. 2024 Jan 1;15(2):484-493. doi: 10.7150/jca.90128. eCollection 2024.
3
Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development.
局部区域联合全身治疗晚期肝细胞癌:快速发展的必然趋势
Front Mol Biosci. 2021 Apr 13;8:635243. doi: 10.3389/fmolb.2021.635243. eCollection 2021.